Brief: Conmed Q4 Adjusted EPS USD 1.43 Vs. IBES Estimate USD 1.32
28/01/2026 21:05
Jan 28 (Reuters) - Conmed Q4 sales USD 373.198 million vs. IBES estimate USD 366.8 million. Q4 pretax profit USD 29.253 million Q4 income from operations USD 36.623 million Q4 EPS USD 0.54 Q4 net income USD 16.739 million outlook FY revenue USD 1,345-1,375 million outlook FY adjusted EPS USD 4.3-4.45
Recent news on Conmed
See all newsBrief: Conmed Enters Agreements To Repurchase 2.25% Convertible Senior Notes Due 2027 On June 3 - SEC Filing
Brief: Conmed Enters First Omnibus Amendment And Increased Facility Activation Notice On May 27, 2026 - SEC Filing
Brief: Conmed Corporation Appoints Celine Martin And Jeff Mirviss To Its Board Of Directors
Medical device maker Conmed raises 2026 organic rev outlook, reaffirms EPS guidance
Brief: Micro-Tech Endoscopy To Acquire Duraclip, Precisor, And Optibite Product Lines From CONMED